reference/3160231

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3160231

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	817.e1
issn	0002-8703
issueIdentifier	5
pageRange	811-817.e1
publicationName	American Heart Journal
startingPage	811
bibliographicCitation	Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives. Am Heart J. 2011 Nov;162(5):811–817.e1. doi: 10.1016/j.ahj.2011.08.012. PMID: 22093195.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a68c89c718cafc18346e462270b3bfdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7138ad2f01a5a3ac222888350454d34d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ae63635c61d359be03209f10a3eabf5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bd56a2924c36c3e21ef0281577da8e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bc2ffc9cb3db0672678cfb1de8c580b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a1c7a8526fea4573c1c42ba3279479b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2029-7847 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5b142972c419443b58497de7910de7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ede77cdd5456c98ea312b1c65568c981 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4328b775b290ecc382b4315a21d53ec9
date	201111
identifier	https://pubmed.ncbi.nlm.nih.gov/22093195 https://doi.org/10.1016/j.ahj.2011.08.012
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/398 https://portal.issn.org/resource/ISSN/0002-8703
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives
discusses	http://id.nlm.nih.gov/mesh/M0001207 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0017012
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000806Q000008 http://id.nlm.nih.gov/mesh/D055118 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D019161Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001118 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012107 http://id.nlm.nih.gov/mesh/D004338
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128043208 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050

Total number of triples: 53.